Cbd Global Sciences Stock Operating Margin
CBDNFDelisted Stock | USD 0.06 0.00 0.00% |
CBD Global Sciences fundamentals help investors to digest information that contributes to CBD Global's financial success or failures. It also enables traders to predict the movement of CBD Pink Sheet. The fundamental analysis module provides a way to measure CBD Global's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CBD Global pink sheet.
CBD |
CBD Global Sciences Company Operating Margin Analysis
CBD Global's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CBD Global Operating Margin | (2.71) % |
Most of CBD Global's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CBD Global Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, CBD Global Sciences has an Operating Margin of -2.7124%. This is 92.27% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 50.77% lower than that of the firm.
CBD Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CBD Global's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CBD Global could also be used in its relative valuation, which is a method of valuing CBD Global by comparing valuation metrics of similar companies.CBD Global is currently under evaluation in operating margin category among its peers.
CBD Fundamentals
Return On Asset | -1.38 | |||
Operating Margin | (2.71) % | |||
Current Valuation | 14.44 M | |||
Shares Outstanding | 49.46 M | |||
Shares Owned By Insiders | 26.61 % | |||
Price To Sales | 2.79 X | |||
Revenue | 166.95 K | |||
Gross Profit | 3.61 K | |||
EBITDA | (4.6 M) | |||
Net Income | (5.25 M) | |||
Cash And Equivalents | 59.92 K | |||
Total Debt | 1.34 M | |||
Current Ratio | 0.09 X | |||
Book Value Per Share | (0.26) X | |||
Cash Flow From Operations | (1.14 M) | |||
Earnings Per Share | (0.11) X | |||
Beta | 0.49 | |||
Market Capitalization | 5.93 M | |||
Total Asset | 2.09 M | |||
Z Score | -4.2 | |||
Net Asset | 2.09 M |
About CBD Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CBD Global Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CBD Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CBD Global Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in CBD Pink Sheet
If you are still planning to invest in CBD Global Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CBD Global's history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |